These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37373593)

  • 1. Investigating the "Fetal Side" in Recurrent Pregnancy Loss: Reliability of Cell-Free DNA Testing in Detecting Chromosomal Abnormalities of Miscarriage Tissue.
    D'Ippolito S; Longo G; Orteschi D; Busnelli A; Di Simone N; Pulcinelli E; Schettini G; Scambia G; Zollino M
    J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal plasma genome-wide cell-free DNA can detect fetal aneuploidy in early and recurrent pregnancy loss and can be used to direct further workup.
    Yaron Y; Pauta M; Badenas C; Soler A; Borobio V; Illanes C; Paz-Y-Miño F; Martinez-Portilla R; Borrell A
    Hum Reprod; 2020 May; 35(5):1222-1229. PubMed ID: 32386059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive cell-free DNA-based approach for the diagnosis of clinical miscarriage: A retrospective study.
    Balaguer N; Rodrigo L; Mateu-Brull E; Campos-Galindo I; Castellón JA; Al-Asmar N; Rubio C; Milán M
    BJOG; 2024 Jan; 131(2):213-221. PubMed ID: 37533357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chromosome analysis of the miscarriage tissue. Miscarried embryo/fetal crown rump length (CRL) measurement: A practical use.
    D'ippolito S; Di Simone N; Orteschi D; Pomponi MG; Genuardi M; Sisti LG; Castellani R; Rossi ED; Scambia G; Zollino M
    PLoS One; 2017; 12(6):e0178113. PubMed ID: 28604823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between chromosomal distribution and embryonic findings on ultrasound in early pregnancy loss after IVF-embryo transfer.
    Ouyang Y; Tan Y; Yi Y; Gong F; Lin G; Li X; Lu G
    Hum Reprod; 2016 Oct; 31(10):2212-8. PubMed ID: 27614356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent pregnancy loss evaluation combined with 24-chromosome microarray of miscarriage tissue provides a probable or definite cause of pregnancy loss in over 90% of patients.
    Popescu F; Jaslow CR; Kutteh WH
    Hum Reprod; 2018 Apr; 33(4):579-587. PubMed ID: 29538673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A minimum estimate of the prevalence of 22q11 deletion syndrome and other chromosome abnormalities in a combined prenatal and postnatal cohort.
    Hui L; Poulton A; Kluckow E; Lindquist A; Hutchinson B; Pertile MD; Bonacquisto L; Gugasyan L; Kulkarni A; Harraway J; Howden A; McCoy R; Costa FDS; Menezes M; Palma-Dias R; Nisbet D; Martin N; Bethune M; Poulakis Z; Halliday J
    Hum Reprod; 2020 Mar; 35(3):694-704. PubMed ID: 32207823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Cell-Free DNA Screening vs Direct Invasive Diagnosis on Miscarriage Rates in Women With Pregnancies at High Risk of Trisomy 21: A Randomized Clinical Trial.
    Malan V; Bussières L; Winer N; Jais JP; Baptiste A; Le Lorc'h M; Elie C; O'Gorman N; Fries N; Houfflin-Debarge V; Sentilhes L; Vekemans M; Ville Y; Salomon LJ;
    JAMA; 2018 Aug; 320(6):557-565. PubMed ID: 30120476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?
    Miranda J; Paz Y Miño F; Borobio V; Badenas C; Rodriguez-Revenga L; Pauta M; Borrell A
    Ultrasound Obstet Gynecol; 2020 May; 55(5):645-651. PubMed ID: 31301176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of tissue from pregnancy loss and aborted fetus with ultrasound anomaly using subtelomeric MLPA and chromosomal array analysis.
    Lou J; Sun M; Zhao Y; Fu Y; Yuan H; Dai Y; Liang F; He Y; Liu Y
    J Matern Fetal Neonatal Med; 2022 Aug; 35(16):3064-3069. PubMed ID: 32811234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
    Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can cell-free DNA (cfDNA) testing alleviate psychological distress in early miscarriage? A commentary.
    Zayyad S; Liang R; Winkel AF; Keefe DL; Quinn GP
    J Assist Reprod Genet; 2022 Jun; 39(6):1219-1224. PubMed ID: 35648322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-Free DNA in the Investigation of Miscarriage.
    Colley E; Devall AJ; Williams H; Hamilton S; Smith P; Morgan NV; Quenby S; Coomarasamy A; Allen S
    J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33114508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities.
    Norton ME; Baer RJ; Wapner RJ; Kuppermann M; Jelliffe-Pawlowski LL; Currier RJ
    Am J Obstet Gynecol; 2016 Jun; 214(6):727.e1-6. PubMed ID: 26709085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of single nucleotide polymorphism microarray analysis in pregnancy loss in Northwest China.
    Xue S; Wang L; Wei J; Liu Y; Ding G; Dai P
    Front Genet; 2023; 14():1319624. PubMed ID: 38155718
    [No Abstract]   [Full Text] [Related]  

  • 16. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
    Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of fetal copy number variants by non-invasive prenatal testing for common aneuploidies.
    Li R; Wan J; Zhang Y; Fu F; Ou Y; Jing X; Li J; Li D; Liao C
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):53-7. PubMed ID: 26033469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
    Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.
    Galeva S; Konstantinidou L; Gil MM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Feb; 53(2):208-213. PubMed ID: 30353581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.